1.
Clin Case Rep
; 9(4): 2228-2235, 2021 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33936671
RESUMO
An 83-year-old female had asymptomatic SARS-CoV-2 infection while taking ruxolitinib. She remained RT-PCR positive for viral RNA for >120 days, and Pegylated interferon for 4 weeks led to viral RNA clearance. The observations support combination therapy of ruxolitinib + interferon for COVID-19.